In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), RPG Life Sciences has informed that the Board of Directors of the Company, at its meeting held today i.e. on Friday, February 02, 2018, has considered and approved the Unaudited Financial Results of the Company for the quarter ended December 31, 2017 along with Limited Review Report of the Statutory Auditors thereon. The Board Meeting commenced at 4.00 p.m. and concluded at 8.15 p.m.
The above information is a part of company’s filings submitted to BSE.
